FSD Pharma Receives Institutional Review Board Approval for Unbuzzd™ Study
Tuesday, 4 June 2024, 09:00
![https://store.livarava.com/a31809e1-226a-11ef-a3ff-9d5fa15a64d8.jpg](https://store.livarava.com/a31809e1-226a-11ef-a3ff-9d5fa15a64d8.jpg)
FSD Pharma Receives Institutional Review Board Approval for Study
An Institutional Review Board has granted FSD Pharma approval to study the safety and efficacy of Unbuzzd™ in Acute Alcohol Intoxication. This milestone marks a significant advancement in the research on Unbuzzd™ and its potential medical benefits.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.